Health Highlights: Dec. 12, 2014

• Tweet
• Pin It

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:

Ebola Vaccine Trial in Switzerland Suspended

Tests on an Ebola vaccine have been temporarily halted after some participants reported concerning side effects, Swiss scientists say.

The clinical trial involving 59 people began in November, but was suspended after four cases of mild joint pain in the hands and feet of volunteers who received the vaccine 10 to 15 days earlier, the Associated Press reported.

The trial was suspended “as a precautionary measure,” and is scheduled to resume in January after a review of the side effects, according to a statement released Thursday by the Hopitaux Universitaires de Geneve.

The same vaccine is being tested in the United States, Canada, Germany and Gabon. It was developed by the Canadian government and is licensed by NewLink and Merck, the AP reported.

Copyright © 2025 HealthDay. All rights reserved.

• Tweet
• Pin It